Home/ sante SANTEMitapivat: Phase 3 trial shows efficacy against sickle cell diseaseAn international phase 3 clinical trial is evaluating the efficacy and safety of mitapivat in patients with sickle cell disease.Published 3sem·1 sourceNotable·updated 3sem Lire en françaisListen≈ 12sSpeed0.8×1×1.2×1.5×🔗Click the link to read an article on the topic:The Lancet↗🧭Explore this topicThe Lancet#drépanocytose#mitapivat#essai clinique#phase 3#maladie génétique#traitement#santé publiqueWhat if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→Follow topic →↗ Share the newsAuto-synthesis from 1 media source · identified on October 23, 2026← Back to home